OrganoClick AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 33.45 million compared to SEK 22.26 million a year ago. Net loss was SEK 4.13 million compared to SEK 9.12 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.09 a year ago.
For the nine months, sales was SEK 117.96 million compared to SEK 93.42 million a year ago. Net loss was SEK 7.79 million compared to SEK 23.83 million a year ago. Basic loss per share from continuing operations was SEK 0.08 compared to SEK 0.24 a year ago.